ARTICLE
|
doi:10.20944/preprints202307.1978.v1
Subject:
Medicine And Pharmacology,
Urology And Nephrology
Keywords:
enfortumab vedotin; urothelial carcinoma; database; real‐world; immune checkpoint
Online: 28 July 2023 (11:46:48 CEST)